Senti Biosciences Holdings, Inc. (SNTI)
Senti Biosciences Holdings, Inc. (SNTI): revenue, margins and EPS from its SEC filings, and Graham's reads as they come out.
Reads
- Senti Biosciences dismisses KPMG and appoints KNAV CPA LLP as its new independent auditor. Dodd · SNTI
From its filings
- Quarter ending 2026-09-30: revenue $19K · operating margin -64852.6% · EPS -0.37 · filed 2026-11-16
- Quarter ending 2026-06-30: revenue $17K · operating margin -85229.4% · EPS -0.41 · filed 2026-08-14
- Quarter ending 2026-03-31: revenue $16K · operating margin -28850.0% · EPS -0.14 · filed 2026-05-14
- Quarter ending 2025-12-31: revenue $22K · operating margin -84709.1% · EPS -0.07 · filed 2026-03-27
- Quarter ending 2025-09-30: revenue $0 · EPS -0.69 · filed 2026-11-16
- Quarter ending 2025-06-30: revenue $0 · EPS -0.56 · filed 2026-08-14
- Quarter ending 2025-03-31: revenue $0 · EPS -1.41 · filed 2026-05-14
- Quarter ending 2024-12-31: revenue $0 · EPS -0.62 · filed 2026-03-27
Source: SEC EDGAR, 10-Q/10-K, as filed.